Effect of Different Injection Regimens of Autologous Conditioned Plasma for Knee Osteoarthritis

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

March 15, 2019

Primary Completion Date

October 17, 2022

Study Completion Date

October 17, 2022

Conditions
Knee Osteoarthritis
Interventions
DRUG

Hyaluronan

Patients will receive 2 intra-articular injections of autologous conditioned plasma and hyaluronic acid once a week for 2 weeks and a third injection on the third week of ACP.

BIOLOGICAL

Autologous conditioned plasma

Patients will receive 3 intra-articular injections of autologous conditioned plasma dosed at once a week for 3 weeks.

Trial Locations (1)

32561

Andrews Institute for Orthopaedics & Sports Medicine, Gulf Breeze

All Listed Sponsors
lead

Andrews Research & Education Foundation

OTHER

NCT03889925 - Effect of Different Injection Regimens of Autologous Conditioned Plasma for Knee Osteoarthritis | Biotech Hunter | Biotech Hunter